Redox-dependent protein kinase regulation by angiotensin II: Mechanistic insights and its pathophysiology

Antioxidants and Redox Signaling

Volumn 7, Issue 9-10, 2005, Pages 1315-1326

  Ohtsu, Haruhiko ^a   Frank, Gerald D ^b   Utsunomiya, Hirotoshi ^c   Eguchi, Satoru ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ENZYME ACTIVATION; FIBROBLAST; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; MESANGIUM CELL; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 24144448984     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1315     Document Type: Review

References (100)

1. Abe J, Deguchi J, Matsumoto T, Takuwa N, Noda M, Ohno M, Makuuchi M, Kurokawa K, and Takuwa Y. Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimai thickening. Circulation 96: 1906-1913, 1997.
2. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, and Yazaki Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100: 1813-1821, 1997.
3. Ardaillou R, Chansel D, Chatziantoniou C, and Dussaule JC. Mesangial AT1 receptors: expression, signaling, and regulation. J Am Soc Nephrol 10 Suppl 11: S40-S46, 1999.
4. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, and Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8: 35-40, 2002.
5. Avraham H, Park SY, Schinkmann K, and Avraham S. RAFTK/Pyk2-mediated cellular signaling. Cell Signal 12: 123-133, 2000.
6. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C1437, 1996.
7. Berk BC. Redox signals that regulate the vascular response to injury. Thromb Haemost 82: 810-817, 1999.
8. Cai H, Li Z, Dikalov S, Holland SM, Hwang J, Jo H, Dudley SC Jr, and Harrison DG. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 277: 48311-48317, 2002.
9. Cheng TH, Cheng PY, Shih NL, Chen IB, Wang DL, and Chen JJ. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 42: 1845-1854, 2003.
10. Costanzo A, Moretti F, Burgio VL, Bravi C, Guido F, Levrero M, and Puri PL. Endothelial activation by angiotensin II through NFkappaB and p38 pathways: involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 195: 402-410, 2003.
11. de Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-172, 2000.
12. Deora AA, Win T, Vanhaesebroeck B, and Lander HM. A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J Biol Chem 273: 29923-29928, 1998.
13. Diez J, Lopez B, Gonzalez A, and Querejeta R. Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol 16: 328-335, 2001.
14. Dostal DE, Hunt RA, Kule CE, Bhat GJ, Karoor V, McWhinney CD, and Baker KM. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways. J Mol Cell Cardiol 29: 2893-2902, 1997.
15. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, and Inagami T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273: 8890-8896, 1998.
16. Eguchi S, Iwasaki H, Hirata Y, Frank GD, Motley ED, Yamakawa T, Numaguchi K, and Inagami T. Epidermal growth factor receptor is indispensable for c-Fos expression and protein synthesis by angiotensin II. Eur J Pharmacol 376: 203-206, 1999.
17. Eguchi S, Iwasaki H, Inagami T, Numaguchi K, Yamakawa T, Motley ED, Owada KM, Marumo F, and Hirata Y. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension 33: 201-206, 1999.
18. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, and Inagami T. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 274: 36843-36851, 1999.
19. Eguchi S, Dempsey PJ, Frank GD, Motley ED, and Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease- dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 276: 7957-7962, 2001.
20. Eguchi S, Frank GD, Mifune M, and Inagami T. Metalloprotease-dependent ErbB ligand shedding in mediating EGFR transactivation and vascular remodeling. Biochem Soc Trans 31: 1198-1202, 2003.
21. Finkel T and Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247, 2000.
22. Frank GD and Eguchi S. Activation of tyrosine kinases by reactive oxygen species in vascular smooth muscle cells: significance and involvement of EGF receptor transactivation by angiotensin II. Antioxid Redox Signal 5: 771-780, 2003.
23. Frank GD, Motley ED, Inagami T, and Eguchi S. PYK2/CAKbeta represents a redox-sensitive tyrosine kinase in vascular smooth muscle cells. Biochem Biophys Res Commun 270: 761-765, 2000.
24. Frank GD, Eguchi S, Inagami T, and Motley ED. N-Acetylcysteine inhibits angiotensin II-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor. Biochem Biophys Res Commun 280: 1116-1119, 2001.
25. Frank GD, Eguchi S, Motley ED, Sasaki T, and Inagami T. Unique regulation of c-Jun N-terminal kinase by PYK2/CAK-beta in angiotensin II-stimulated vascular smooth muscle cells. Biochem Biophys Res Commun 286: 692-696, 2001.
26. 2+ and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2. Mol Endocrinol 16: 367-377, 2002.
27. Frank GD, Mifune M, Inagami T, Ohba M, Sasaki T, Higashiyama S, Dempsey PJ, and Eguchi S. Distinct mech-anisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta. Mol CellBiol 23: 1581-1589, 2003.
28. Gonzalez-Rubio M, Voit S, Rodriguez-Puyol D, Weber M, and Marx M. Oxidative stress induces tyrosine phosphorylation of PDGF alpha- and beta-receptors and pp60c-src in mesangial cells. Kidney Int 50: 164-173, 1996.
29. Gorin Y, Kim NH, Feliers D, Bhandari B, Choudhury GG, and Abboud HE. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. Faseb J 15: 1909-1920, 2001.
30. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, and Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285: F219-F229, 2003.
31. Gorin Y, Ricono JM, Wagner B, Kim NH, Bhandari B, Ghosh Choudhury G, and Abboud HE. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J 381 (Pt 1): 231-239, 2004.
32. Gray MO, Long CS, Kalinyak JE, Li HT, and Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 40: 352-363, 1998.
33. Griendling KK and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91: 21-21, 2000.
34. Griendling KK, Ushio-Fukai M, Lassegue B, and Alexander RW. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 29: 366-373, 1997.
35. Griendling KK, Sorescu D, Lassegue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000.
36. Gschwind A, Zwick E, Prenzel N, Leserer M, and Ullrich A. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for inter-receptor signal transmission. Oncogene 20: 1594-1600, 2001.
37. Heeneman S, Haendeler J, Saito Y, Ishida M, and Berk BC. Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein She. J Biol Chem 275: 15926-15932, 2000.
38. Heldin CH. Simultaneous induction of stimulatory and inhibitory signals by PDGF. FEBS Lett 410: 17-21, 1997.
39. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M, and Hori M. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105: 509-515, 2002.
40. Hsu YH, Chen JJ, Chang NC, Chen CH, Liu JC, Chen TH, Jeng CJ, Chao HH, and Cheng TH. Role of reactive oxygen species-sensitive extracellular signal-regulated kinase pathway in angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells. J Vasc Res 41: 64-74, 2004.
41. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, and Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94, 1997.
42. Ishida T, Ishida M, Suero J, Takahashi M, and Berk BC. Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest 103: 789-797, 1999.
43. Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A, Ichijo H, and Iwao H. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ Res 93: 874-883, 2003.
44. Jaimes EA, Galceran JM, and Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54: 775-784, 1998.
45. Kagiyama S, Eguchi S, Frank GD, Inagami T, Zhang YC, and Phillips MI. Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 106: 909-912, 2002.
46. 2- mediated permeability II: Importance of tyrosine phosphatase and kinase activity. Am J Physiol Cell Physiol 281: C1940-C1947. 2001.
47. Kim S and Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52: 11-34, 2000.
48. Knebel A, Rahmsdorf HJ, Ullrich A, and Herrlich P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. Embo J 15: 5314-5325, 1996.
49. Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, and Beckman JS. Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med 25: 812-819, 1997.
50. Lander HM, Milbank AJ, Tauras JM, Hajjar DP, Hempstead BL, Schwartz GD, Kraemer RT, Mirza UA, Chait BT, Burk SC, and Quilliam LA. Redox regulation of cell signaling. Nature 381: 380-381, 1996.
51. Liu JC, Cheng TH, Lee HM, Lee WS, Shih NL, Chen YL, Chen JJ, and Chan P. Inhibitory effect of trilinolein on angiotensin II-induced cardiomyocyte hypertrophy. Eur J Pharmacol 484: 1-8, 2004.
52. Lu D, Maulik N, Moraru II, Kreutzer DL, and Das DK. Molecular adaptation of vascular endothelial cells to oxidative stress. Am J Physiol 264: C715-C722, 1993.
53. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, and Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375: 241-250, 1995.
54. Martindale JL and Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1-15, 2002.
55. McWhinney CD, Dostal D, and Baker K. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. J Mol Cell Cardiol 30: 751-761, 1998.
56. Mezzano SA, Ruiz-Ortega M, and Egido J. Angiotensin 11 and renal fibrosis. Hypertension 38: 635-638, 2001.
57. Mihm MJ, Wattanapitayakul SK, Piao SF, Hoyt DG, and Bauer JA. Effects of angiotensin II on vascular endothelial cells: formation of receptor-mediated reactive nitrogen species. Biochem Pharmacol 65: 1189-1197, 2003.
58. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, and Munzel T. Effects of angiotensin Il infusion on the expression and function OfNAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-E65, 2002.
59. Mombouli JV and Vanhoutte PM. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol 31: 61-74, 1999.
60. Mondorf UF, Geiger H, Herrero M, Zeuzem S, and Piiper A. Involvement of the platelet-derived growth factor receptor in angiotensin II-induced activation of extracellular regulated kinases 1 and 2 in human mesangial cells. FEBS Lett 472: 129-132, 2000.
61. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, and Namba M. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98: 794-799, 1998.
62. Nishida M, Maruyama Y, Tanaka R, Kontani K, Nagao T, and Kurose H. G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature 408: 492-495, 2000.
63. Rane SG and Reddy EP. Janus kinases: components of multiple signaling pathways. Oncogene 19: 5662-5679, 2000.
64. Rhee SG, Bae YS, Lee SR, and Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000: PE1, 2000.
65. 2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the 1CAM-1 promoter. J Biol Chem 270: 18966-18974, 1995.
66. Rossi GP, Sacchetto A, Cesari M, and Pessina AC. Interactions between endothelin-1 and the rennin-angiotensin-aldosterone system. Cardiovasc Res 43: 300-307, 1999.
67. Rueckschloss U, Quinn MT, Holtz J, and Morawietz H. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 22: 1845-1851, 2002.
68. Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, and Egido J. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 86: 1266-1272, 2000.
69. Sabri A, Govindarajan G, Griffin TM, Byron KL, Samarel AM, and Lucchesi PA. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. Circ Res 83: 841-851, 1998.
70. Sabri A, Hughie HH, and Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 5: 731-740, 2003.
71. Sadoshima J and Izumo S. The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 15: 775-787, 1996.
72. Saito S, Frank GD, Mifune M, Ohba M, Utsunomiya H, Motley ED, Inagami T, and Eguchi S. Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src. J Biol Chem 111: 44695-44700. 2002.
73. Saito S, Frank GD, Motley ED, Dempsey PJ, Utsunomiya H, Inagami T, and Eguchi S. Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. Biochem Biophys Res Commun 294: 1023-1029, 2002.
74. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, and Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 87: 1195-1201, 2000.
75. Schmidt-Ott KM, Kagiyama S, and Phillips MI. The multiple actions of angiotensin II in atherosclerosis. Regul Pept 93: 65-77, 2000.
76. Seals DF and Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17: 7-30, 2003.
77. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD (P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002.
78. Seta K and Sadoshima J. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor. J Biol Chem 278: 9019-9026, 2003.
79. Shih NL, Cheng TH, Loh SH, Cheng PY, Wang DL, Chen YS, Liu SH, Liew CC, and Chen JJ. Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes. Biochem Biophys Res Commun 283: 143-148, 2001.
80. Sun X, Wu F, Datta R, Kharbanda S, and Kufe D. Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem 275: 7470-7473, 2000.
81. Suzuki M, Raab G, Moses MA, Fernandez CA, and Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem 272: 31730-31737, 1997.
82. Thomas SM and Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513-609, 1997.
83. Thomas WG, Brandenburger Y, Autelitano DJ, Pham T, Qian H, and Hannan RD. Adenoviral-directed expression of the type IA angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ Res 90: 135-142, 2002.
84. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathphysiology. Antioxid Redox Signal 7: 1302-1314, 2005.
85. Touyz RM and Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
86. Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, and Schiffrin EL. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol 81: 159-167, 2003.
87. Touyz RM, Yao G, and Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23: 981-987, 2003.
88. Ushio-Fukai M, Alexander RW, Akers M, and Griendling KK. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029, 1998.
89. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, and Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274: 22699-22704, 1999.
90. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, and Alexander RW. Epidermal growth factor receptor transactivation by angiotensin 11 requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 489-495, 2001.
91. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kubler W, and Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arteriosder Thromb Vasc Biol 20: 940-948, 2000.
92. Wang D, Yu X, and Brecher P. Nitric oxide and N-acetylcysteine inhibit the activation of mitogen-activated protein kinases by angiotensin II in rat cardiac fibroblasts. J Biol Chem 273: 33027-33034, 1998.
93. 2+ levels. J Biol Chem 275: 12223-12230, 2000.
94. Xie Z, Pimentai DR, Lohan S, Vasertriger A, Pligavko C, Colucci WS, and Singh K. Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species. J Cell Physiol 188: 132-138, 2001.
95. Yamaoka-Tojo M, Ushio-Fukai M, Hilenski L, Dikalov SI, Chen YE, Tojo T, Fukai T, Fujimoto M, Patrushev NA, Wang N, Kontos CD, Bloom GS, and Alexander RW. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen speciesdependent endothelial migration and proliferation. Circ Res 95: 276-283, 2004.
96. Van C, Kim D, Aizawa T, and Berk BC. Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator. Arteriosder Thromb Vasc Biol 23: 26-36, 2003.
97. Yin G, Van C, and Berk BC. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 35: 780-783, 2003.
98. Yoshizumi M, Abe J, Haendeler J, Huang Q, and Berk BC. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 275: 11706-11712, 2000.
99. Zent R, Ailenberg M, Downey GP, and Silverman M. ROS stimulate reorganization of mesangial cell-collagen gels by tyrosine kinase signaling. Am J Physiol 276: F278-F287, 1999.
100. Zhang Z, Oliver P, Lancaster JJ, Schwarzenberger PO, Joshi MS, Cork J, and Kolls JK. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J 15: 303-305, 2001.